Local anti-osteolytic/anti-inflammatory treatment showed no significant effects on peri-implant inflammatory infiltrate in peri-implantitis under diabetic conditions (DM+lig+RANKL Ab+miR146a vs. DM+lig) (Fig. 2B). This evidence concerns the gene TNFSF11 and Peri-Implantitis.